Final-Program-ATS-2023-AP.vp

180

MONDAY • MAY 22

P1272 Suppression by Clarithromycin of IL-8 Production From Human Airway Epithelial Cells Treated With Prevotella Intermedia Supernatants/ N. Iwanaga, Nagasaki, Japan P1273 Chemical Induction of Type I Diabetes Renders Mice More Susceptible to SARS-CoV-2-induced Lung Injury/ S. Kass-Gergi, Philadelphia, PA P1274 Effects of Hypercapnia on Alveolar Epithelial Cells and Macrophages Infected With Pneumonia-causing Bacteria/ E. Campaña Duel, Sabadell, Spain P1275 Functional Phenotype of Recruited Monocytes in the Subacute Phase of Mice Peritoneal Sepsis; Possible Association With the Immunosuppressive Phenotype/ Q. Meng, Bunkyo-ku, Japan P1276 Carbon Monoxide Improves Human Mesenchymal Stromal Cell Function During Polymicrobial Sepsis by Induction of Autophagy/ N. Hwang, Boston, MA P1277 Hox5 Expression in Acute Lung Injury/ C. Hauser, Madison, WI P1278 Redox Regulation of Influenza Neuraminidase by Protein Disulfide Isomerase A3/ M. Ruban, Burlington, VT P1279 GS-441524 Parent Nucleoside to Remdesivir Can Effectively Inhibits Sars-Cov-2 Omicron Infections in Human Lung Organoids/ J. Liang, Toronto, Canada P1280 Tissue Pathologic Role of Cd8 + T Cells During Influenza/ N. Khan, Gainesville, FL P1281 The PTP4A3 Inhibitor, KVX-053, Ameliorates Alcohol-exacerbated SARS-CoV-2-induced ARDS/ P.A. Solopov, Norfolk, VA

P1284 CNI-103, a Cell Permeable Peptide Inhibitor of the Calcineurin, Alters the Composition and Function of Extracellular Vesicles in Mouse Bronchoalveolar Lavage Fluid During Acute Lung Injury/ M. Karpurapu, Columbus, OH P1285 Endothelial Cell Targeted Nanoparticles Concentrate in Pulmonary Marginated Neutrophils During Acute Respiratory Distress Syndrome/ E.-O. Essien, Philadelphia, PA P1286 Neutrophil-like Ly6C hi Monocytes Enhance the Lung Injury Response in Sepsis Survivor Mice/ S.J. Denstaedt, Ann Arbor, MI P1287 A Single-cell RNA Sequencing Comparison of Pulmonary Macrophages From LPS- and Bleomycin-treated Mice Reveals a Novel Macrophage Subset Associated With Prolonged Inflammation and Fibrosis/ E. King, Denver, CO P1288 Lung Innate Immune Response in the Subacute Phase of Gut Ischemia/Reperfusion; Mouse Model/ F. Seto, Bunkyo-ku, Japan P1289 Acid Sphingomyelinase Induces the Release of Alveolar Macrophage-derived Microvesicles During Acute Lung Injury/ X. Cheng, London, United Kingdom P1290 Endothelial Derived IL33 Induces Fibrogenesis and Is Associated With CLAD/ M. Banday, Boston, MA P1291 Intra-alveolar Neutrophil-derived Microvesicles After One-lung Ventilation Are Associated With Post-operative Pulmonary Complications in Patients Undergoing Esophagectomy/ J. Stephens, London, United Kingdom P1292 Impaired Lung Functioning Following Chronic Ozone Exposure Is Associated With Inflammatory Macrophage Activation and Altered Bioenergetics/ V. Sunil, Piscataway, NJ P1293 Factor XIII Limits Recruitment and Activation of Alveolar Macrophages After Lipopolysaccharide/ P.K. Moore, Aurora, CO P1294 Steroid Induced Modulation of Myeloid Derived Suppressor Cells Results in Increased Suppressor Activity/ M. Berlinger, Baltimore, MD P1295 Vitamin E Acetate Aerosol Induces Hemeoxygenase-1 and Cytochrome P4501A1 mRNA Expression in Human U937 Macrophages/ X. Li, Davis, CA P1296 Sex Differences in Immune Response to Extracellular Matrix Nanoparticle Treatment of Endotoxin-induced Lung Injury/ C. Slaybaugh, Richmond, VA P1297 Early Sphingolipid Changes in the Development of Niemann-Pick Disease (NPD) in Mice and the Impact on Acute Lung Inflammation/ J.M. Poczobutt, Denver, CO

BASIC • TRANSLATIONAL THEMATIC POSTER SESSION

B67

ALL THE LUNG’S A STAGE: IMMUNE CELLS ARE THE PLAYERS

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area L, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion

12:15-1:15 authors will be present for discussionwith assigned facilitators.

P1283 Upregulation of Key Inflammatory Mediators in

Broncho-alveolar Lavage Fluids From Lung Transplant Recipients With Chronic Lung Allograft Dysfunction/ F. Fattahi, Ann Arbor, MI

ATS 2023 • Washington, DC